<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.com/index.php?action=history&amp;feed=atom&amp;title=Nitecapone</id>
	<title>Nitecapone - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.com/index.php?action=history&amp;feed=atom&amp;title=Nitecapone"/>
	<link rel="alternate" type="text/html" href="https://wikimd.com/index.php?title=Nitecapone&amp;action=history"/>
	<updated>2026-04-21T05:12:54Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.com/index.php?title=Nitecapone&amp;diff=5807148&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.com/index.php?title=Nitecapone&amp;diff=5807148&amp;oldid=prev"/>
		<updated>2024-05-22T16:21:47Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:Nitecapone.svg|thumb|Nitecapone.svg]] &amp;#039;&amp;#039;&amp;#039;Nitecapone&amp;#039;&amp;#039;&amp;#039; is a chemical compound that functions as a [[catechol-O-methyltransferase]] (COMT) inhibitor. It has been studied for its potential therapeutic effects, particularly in the treatment of [[Parkinson&amp;#039;s disease]].&lt;br /&gt;
&lt;br /&gt;
==Mechanism of Action==&lt;br /&gt;
Nitecapone works by inhibiting the enzyme [[catechol-O-methyltransferase]] (COMT). This enzyme is responsible for the breakdown of [[catecholamines]], including important neurotransmitters such as [[dopamine]], [[epinephrine]], and [[norepinephrine]]. By inhibiting COMT, nitecapone increases the levels of these neurotransmitters in the brain, which can help alleviate symptoms of [[Parkinson&amp;#039;s disease]].&lt;br /&gt;
&lt;br /&gt;
==Therapeutic Use==&lt;br /&gt;
Nitecapone has been primarily investigated for its use in [[Parkinson&amp;#039;s disease]]. This neurodegenerative disorder is characterized by the loss of [[dopaminergic neurons]] in the [[substantia nigra]], leading to a decrease in [[dopamine]] levels. By inhibiting COMT, nitecapone helps to maintain higher levels of [[dopamine]] in the brain, which can improve motor function and reduce symptoms such as [[tremor]], [[rigidity]], and [[bradykinesia]].&lt;br /&gt;
&lt;br /&gt;
==Pharmacokinetics==&lt;br /&gt;
The pharmacokinetics of nitecapone involve its absorption, distribution, metabolism, and excretion. After administration, nitecapone is absorbed into the bloodstream and distributed throughout the body. It is metabolized primarily in the liver and excreted through the kidneys.&lt;br /&gt;
&lt;br /&gt;
==Side Effects==&lt;br /&gt;
As with any medication, nitecapone can have side effects. Common side effects include [[nausea]], [[vomiting]], and [[diarrhea]]. More serious side effects can include [[liver dysfunction]] and [[allergic reactions]]. Patients taking nitecapone should be monitored regularly for any adverse effects.&lt;br /&gt;
&lt;br /&gt;
==Research and Development==&lt;br /&gt;
Nitecapone is still under investigation, and more research is needed to fully understand its efficacy and safety profile. Clinical trials are ongoing to determine its potential benefits and risks in the treatment of [[Parkinson&amp;#039;s disease]] and other conditions.&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
* [[Parkinson&amp;#039;s disease]]&lt;br /&gt;
* [[Catechol-O-methyltransferase]]&lt;br /&gt;
* [[Dopamine]]&lt;br /&gt;
* [[Neurotransmitter]]&lt;br /&gt;
* [[Substantia nigra]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist}}&lt;br /&gt;
&lt;br /&gt;
==External Links==&lt;br /&gt;
{{Commons category|Nitecapone}}&lt;br /&gt;
&lt;br /&gt;
[[Category:COMT inhibitors]]&lt;br /&gt;
[[Category:Parkinson&amp;#039;s disease]]&lt;br /&gt;
[[Category:Neuropharmacology]]&lt;br /&gt;
[[Category:Experimental drugs]]&lt;br /&gt;
&lt;br /&gt;
{{medicine-stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>